These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24030866)

  • 1. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.
    Hope VD; McVeigh J; Marongiu A; Evans-Brown M; Smith J; Kimergård A; Croxford S; Beynon CM; Parry JV; Bellis MA; Ncube F
    BMJ Open; 2013 Sep; 3(9):e003207. PubMed ID: 24030866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
    Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15.
    Hope VD; McVeigh J; Smith J; Glass R; Njoroge J; Tanner C; Parry JV; Ncube F; Desai M
    Drug Alcohol Depend; 2017 Oct; 179():83-86. PubMed ID: 28759821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs.
    Hope VD; McVeigh J; Begley E; Glass R; Edmundson C; Heinsbroek E; Kean J; Campbell J; Whitfield M; Morgan G; Acreman D; Smith J
    Drug Alcohol Rev; 2021 May; 40(4):586-596. PubMed ID: 33164293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.
    Glass R; Hope VD; Njoroge J; Edmundson C; Smith J; McVeigh J; Parry J; Desai M
    Drug Alcohol Depend; 2019 Feb; 195():40-44. PubMed ID: 30580202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
    van Beek I; Chronister KJ
    Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hustling, injection drug use, and non-gay identification by men who have sex with men. Associations with high-risk sexual behaviors and condom use.
    Rietmeijer CA; Wolitski RJ; Fishbein M; Corby NH; Cohn DL
    Sex Transm Dis; 1998 Aug; 25(7):353-60. PubMed ID: 9713915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales.
    Crampin AC; Lamagni TL; Hope VD; Newham JA; Lewis KM; Parry JV; Gill ON
    Epidemiol Infect; 1998 Oct; 121(2):381-6. PubMed ID: 9825789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.
    Hope VD; McVeigh J; Marongiu A; Evans-Brown M; Smith J; Kimergård A; Parry JV; Ncube F
    Epidemiol Infect; 2015 Jan; 143(1):132-40. PubMed ID: 24713416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image and performance enhancing drug use among men who have sex with men and women who have sex with women in the UK.
    Hibbert MP; Brett CE; Porcellato LA; Hope VD
    Int J Drug Policy; 2021 Sep; 95():102933. PubMed ID: 32912823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.
    Van de Ven K; Maher L; Wand H; Memedovic S; Jackson E; Iversen J
    Drug Alcohol Rev; 2018 Nov; 37(7):837-846. PubMed ID: 29968372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of bloodborne viruses and associated risk behaviours in Greek prisons.
    Malliori M; Sypsa V; Psichogiou M; Touloumi G; Skoutelis A; Tassopoulos N; Hatzakis A; Stefanis C
    Addiction; 1998 Feb; 93(2):243-51. PubMed ID: 9624725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.